Sutro Biopharma, Inc. (STRO) Financial Statements (2024 and earlier)

Company Profile

Business Address 111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments334,364197,938368,137117,864204,492
Cash and cash equivalents47,25430,414206,1524,960125,298
Short-term investments287,110167,524161,985112,90479,194
Receivables7,12212,4545,5597,3483,448
Other undisclosed current assets11,6678,1234,4863,3562,006
Total current assets:353,153218,515378,182128,568209,946
Noncurrent Assets
Operating lease, right-of-use asset26,44329,041  
Property, plant and equipment24,62122,55012,9359,63310,934
Long-term investments and receivables  68,775 15,609 
Long-term investments  68,775 15,609 
Restricted cash and investments8728728721515
Other noncurrent assets1,8551,6552,1222,5452,244
Total noncurrent assets:53,791122,89315,92927,80213,193
TOTAL ASSETS:406,944341,408394,111156,370223,139
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17,93922,74414,36711,6019,278
Accounts payable4,79711,3275,5445,5843,061
Accrued liabilities13,14211,4178,8236,0176,217
Deferred revenue16,7595,49614,60319,465
Debt12,5009,375 1,0004,724
Contract with customer, liability21,574
Other liabilities3,0803,084627901847
Other undisclosed current liabilities16,2691,037   
Total current liabilities:66,54741,73629,59732,96736,423
Noncurrent Liabilities
Long-term debt and lease obligation 3,77146,96224,5458,87610,000
Long-term debt, excluding current maturities 3,77115,73824,5458,87610,000
Liabilities, other than long-term debt119,5781467,92116,73845,177
Deferred revenue89,885 6,10016,195
Contract with customer, liability44,599
Deferred rent credit   1,340409476
Other liabilities 119146481134102
Operating lease, liability29,57431,224  
Other undisclosed noncurrent liabilities     
Total noncurrent liabilities:123,34947,10832,46625,61455,177
Total liabilities:189,89688,84462,06358,58191,600
Equity
Equity, attributable to parent217,048252,564332,04897,789131,539
Common stock5846462323
Additional paid in capital670,223586,243559,746293,346281,891
Accumulated other comprehensive income (loss)(618)(314)129165(47)
Accumulated deficit(452,615)(333,411)(227,873)(195,745)(150,328)
Total equity:217,048252,564332,04897,789131,539
TOTAL LIABILITIES AND EQUITY:406,944341,408394,111156,370223,139

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues67,77261,88042,72242,73638,419
Revenue from related parties  2,81322,536 
Gross profit:67,77261,88042,72242,73638,419
Operating expenses(196,715)(160,404)(113,779)(98,204)(75,642)
Operating loss:(128,943)(98,524)(71,057)(55,468)(37,223)
Nonoperating income3,4555771,5084,0743,529
Investment income, nonoperating3,4555771,5084,0741,616
Other nonoperating income     1,913
Interest and debt expense(2,400)(2,600)(2,300)(1,100)(1,623)
Loss from continuing operations before equity method investments, income taxes:(127,888)(100,547)(71,849)(52,494)(35,317)
Other undisclosed income from continuing operations before income taxes11,184    
Loss from continuing operations before income taxes:(116,704)(100,547)(71,849)(52,494)(35,317)
Income tax expense(2,500) (100)  
Loss from continuing operations:(119,204)(100,547)(71,949)(52,494)(35,317)
Loss before gain (loss) on sale of properties:(100,547)(71,949)(52,494)(35,317)
Other undisclosed net income (loss)  (4,991)39,821(3,250) 
Net loss:(119,204)(105,538)(32,128)(55,744)(35,317)
Other undisclosed net income attributable to parent     
Net loss available to common stockholders, diluted:(119,204)(105,538)(32,128)(55,744)(35,317)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(119,204)(105,538)(32,128)(55,744)(35,317)
Comprehensive loss:(119,204)(105,538)(32,128)(55,744)(35,317)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(304)(443)(36)212(47)
Comprehensive loss, net of tax, attributable to parent:(119,508)(105,981)(32,164)(55,532)(35,364)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: